Studio Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $280K | Hold |
689
| – | – | 0.06% | 155 |
|
2025
Q1 | $343K | Sell |
689
-47
| -6% | -$23.4K | 0.07% | 140 |
|
2024
Q4 | $383K | Sell |
736
-58
| -7% | -$30.2K | 0.08% | 124 |
|
2024
Q3 | $491K | Buy |
794
+26
| +3% | +$16.1K | 0.1% | 112 |
|
2024
Q2 | $425K | Buy |
768
+16
| +2% | +$8.86K | 0.1% | 111 |
|
2024
Q1 | $437K | Buy |
752
+51
| +7% | +$29.7K | 0.1% | 113 |
|
2023
Q4 | $372K | Sell |
701
-109
| -13% | -$57.9K | 0.09% | 116 |
|
2023
Q3 | $410K | Buy |
810
+42
| +5% | +$21.3K | 0.11% | 98 |
|
2023
Q2 | $401K | Buy |
768
+75
| +11% | +$39.2K | 0.11% | 101 |
|
2023
Q1 | $400K | Buy |
693
+2
| +0.3% | +$1.15K | 0.12% | 96 |
|
2022
Q4 | $381K | Buy |
691
+35
| +5% | +$19.3K | 0.12% | 92 |
|
2022
Q3 | $333K | Buy |
656
+4
| +0.6% | +$2.03K | 0.12% | 100 |
|
2022
Q2 | $354K | Buy |
652
+226
| +53% | +$123K | 0.12% | 95 |
|
2022
Q1 | $252K | Buy |
426
+18
| +4% | +$10.6K | 0.08% | 100 |
|
2021
Q4 | $272K | Buy |
408
+44
| +12% | +$29.3K | 0.1% | 101 |
|
2021
Q3 | $208K | Buy |
+364
| New | +$208K | 0.09% | 101 |
|